Danaher to Present at Evercore ISI HealthCONx Conference
Get Alerts DHR Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 0.7%
Revenue Growth %: +8.4%
Join SI Premium – FREE
ABOUT DANAHER
Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. Our businesses partner closely with customers to solve many of the most important health challenges impacting patients around the world. Danaher's advanced science and technology - and proven ability to innovate - help enable faster, more accurate diagnoses and help reduce the time and cost needed to sustainably discover, develop and deliver life-changing therapies. Focused on scientific excellence, innovation and continuous improvement, our 65,000+ associates worldwide help ensure that Danaher is improving quality of life for billions of people today, while setting the foundation for a healthier, more sustainable tomorrow. Explore more at www.danaher.com.
Danaher Corporation,
View original content:https://www.prnewswire.com/news-releases/danaher-to-present-at-evercore-isi-healthconx-conference-301995195.html
SOURCE Danaher Corporation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Celltrion to Present New Analyses of ZYMFENTRA® (infliximab-dyyb) in Crohn's Disease and Ulcerative Colitis at ACG 2026
- Crypto News: Remittix Opens PayFi to 1,000 Holders as Bitcoin Price Prediction Explodes to $200,000 and Solana’s 200ms Upgrade Fuels a $300 SOL Target
- Beltone Asset Management and Amtaar Partner on a Multi-Issuance Real Estate Investment Fund with EGP 2 Billion in Targeted Issuances
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share